Hearing Loss Trial, Recruiting (NCT06493825)

Hearing Loss Trial, Recruiting NCT06493825 Sponsor: University of Colorado, Denver Condition: Hearing Loss

Printed from Voxsanity (voxsanity.com.au) — NCT06493825 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hearing Loss

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Children and teenagers between the ages of 10 and 18 years old
Children of any gender or ethnic background
Children who have been assessed and found to have "severe" symptoms of both tinnitus (ringing or noise in the ears) and misophonia (strong negative reactions to certain sounds), based on specific scoring tools used by the trial team

Who may not be able to join:

Children with a severe developmental delay that would make it too difficult for them to follow spoken instructions needed to use the virtual reality (VR) equipment in the study
Children with serious vision problems (note: wearing glasses or contact lenses for conditions like short or long-sightedness is generally acceptable)
Children who have any type of hearing loss in one or both ears
Children who have a history of seizures (epilepsy or other seizure conditions)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 720-777-8502

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06493825

Sponsor: University of Colorado, Denver

Phase: Not Applicable

Status: Recruiting

Condition: Hearing Loss

Trial contact: 720-777-8502

More information: https://clinicaltrials.gov/study/NCT06493825

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Children and teenagers between the ages of 10 and 18 years old
Children of any gender or ethnic background
Children who have been assessed and found to have "severe" symptoms of both tinnitus (ringing or noise in the ears) and misophonia (strong negative reactions to certain sounds), based on specific scoring tools used by the trial team

Who may not be able to join:

Children with a severe developmental delay that would make it too difficult for them to follow spoken instructions needed to use the virtual reality (VR) equipment in the study
Children with serious vision problems (note: wearing glasses or contact lenses for conditions like short or long-sightedness is generally acceptable)
Children who have any type of hearing loss in one or both ears
Children who have a history of seizures (epilepsy or other seizure conditions)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Colorado, Denver

Registry

ClinicalTrials.gov

Start date

1 September 2024

Est. completion

15 December 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Tinnitus Functional Index (TFI); Amsterdam Misophonia Scale (A-MIS-S); Pediatric Quality of Life PedQL); Screen for Child Anxiety Related Emotional Disorders (SCARED); Short Mood and Feelings Questionnaire (SMFQ); Tinnitus Functional Index (TFI); Amsterdam Misophonia Scale (A-MIS-S); Pediatric Quality of Life PedQL); Screen for Child Anxiety Related Emotional Disorders (SCARED); Short Mood and Feelings Questionnaire (SMFQ)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov